Anaplastic large cell lymphoma historical perspective
|
Anaplastic large cell lymphoma Microchapters |
|
Differentiating Anaplastic large cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anaplastic large cell lymphoma historical perspective On the Web |
|
American Roentgen Ray Society Images of Anaplastic large cell lymphoma historical perspective |
|
FDA on Anaplastic large cell lymphoma historical perspective |
|
CDC on Anaplastic large cell lymphoma historical perspective |
|
Anaplastic large cell lymphoma historical perspective in the news |
|
Blogs on Anaplastic large cell lymphoma historical perspective |
|
Directions to Hospitals Treating Anaplastic large cell lymphoma |
|
Risk calculators and risk factors for Anaplastic large cell lymphoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2], Kamal Akbar, M.D.[3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]
Overview
Anaplastic lymphoma was first described by Stien et al in 1985. In 2008, the World Health Organization (WHO) added anaplastic lymphoma kinase (ALK) negative anaplastic large cell lymphoma and anaplastic lymphoma kinase positive large B-cell lymphoma as transitional bodies in the peripheral T-cell lymphoma classification.[1][2]
Historical Perspective
- Anaplastic large cell lymphoma was first described by Stein et al in 1985, whom described it as neoplastic proliferation of lymphoid cells which appears anaplastic. When tumor cells always showed labeling by the monoclonal antibody Ki-1, a marker later shown to recognize the CD30 antigen.[3]
- In 1988, ALCL was added to the revised Kiel classification.
- In 1994, it was included in the Revised European-American Lymphoma (REAL) classification.[3]
- Then in 1997, Delsol discovered anaplastic lymphoma kinase-(ALK-) positive large B-cell lymphoma (ALK+ LBCL).
- In 2008, the World Health Organization (WHO) added anaplastic lymphoma kinase (ALK) negative anaplastic large cell lymphoma and anaplastic lymphoma kinase positive large B-cell lymphoma as provisional entities in the peripheral T-cell lymphoma classification.[1][2]
References
- ↑ 1.0 1.1 "Anaplastic large cell lymphoma, ALK-negative".
- ↑ 2.0 2.1 Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma: An Underrecognized Aggressive Lymphoma. Hindawi Publishing Corporation. http://www.hindawi.com/journals/ah/2012/529572/#B1 Accessed on October 13, 2015
- ↑ 3.0 3.1 Montes-Mojarro IA, Steinhilber J, Bonzheim I, Quintanilla-Martinez L, Fend F (2018). "The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL)". Cancers (Basel). 10 (4). doi:10.3390/cancers10040107. PMC 5923362. PMID 29617304.